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Abstract We examined the pathway of prostaglandin E2
(PGE2)-induced internalization of the prostaglandin EP4 re-
ceptor in HEK 293 cells. Co-expression of dominant negative L-
arrestin (319^418) or dynamin I (K44A) with the EP4 receptor
reduced internalization. The activated receptor co-localized with
GFP-arrestin 2 and GFP-arrestin 3, confirming the requirement
for L-arrestins in internalization. Inhibition of clathrin-coated
vesicle-mediated internalization resulted in inhibition of seques-
tration, whereas inhibition of caveola-mediated internalization
had no effect. PGE2 stimulation of the EP4 receptor resulted in
rapid mitogen-activated protein (MAP) kinase activation.
Examination of an internalization-resistant mutant and co-
expression of mutant accessory proteins with EP4 revealed that
MAP kinase activation proceeds independently of inter-
nalization. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Prostaglandin E2 (PGE2) is involved in many physiological
and pathological events including regulation of blood £ow,
cytoprotection and in£ammation [1]. PGE2 acts through
four G protein-coupled receptors (GPCRs), designated EP1,
EP2, EP3 and EP4, which are encoded by di¡erent genes [2].
The EP1 receptor couples to phospholipase C, the EP2 and
EP4 receptors couple to stimulation of adenylyl cyclase, while
the EP3 receptor couples to inhibition of adenylyl cyclase.
The prostaglandin EP4 receptor displays broad tissue dis-
tribution, with high levels in the small intestine, thymus,
lungs, spleen, heart and uterus [3]. Gene knockout of the
receptor shows that it is involved in closure of the ductus
arteriosus at birth [4,5].
The EP4 receptor is a 488 amino acid protein with a long
cytoplasmic tail, which has previously been implicated in ag-
onist-induced desensitization [6]. We localized the region in-
volved to a 14 amino acid stretch containing six serine resi-
dues [7]. Recently, we showed that the carboxy tail of the
human EP4 receptor also participates in agonist-induced in-
ternalization. Successive truncation of the carboxy-terminus
resulted in gradual attenuation of internalization although
mutation of 10 serine and one threonine residues had no e¡ect
on internalization [8].
Internalization of GPCRs involves rapid receptor^G pro-
tein uncoupling followed by translocation of receptors from
the plasma membrane to intracellular vesicles [9]. The process-
es underlying internalization have been widely studied, with
the L2-adrenergic receptor (L2AR) serving as the paradigm for
other GPCRs [10,11]. However, it has become increasingly
apparent that the molecular events responsible for L2AR reg-
ulation do not necessarily apply to all GPCRs. There appear
to be at least two distinct pathways [12]. The pathway for
which the L2AR is the prototype involves agonist-induced
phosphorylation of the receptor by G protein-coupled recep-
tor kinases, followed by L-arrestin binding [13^15]. The recep-
tor^L-arrestin complex binds to clathrin and is subsequently
internalized in a process dependent on the GTPase, dynamin
[16,17]. Another mechanism, implicated in internalization of
the angiotensin II type 1A receptor, does not involve either L-
arrestin or dynamin [17]. Agonist-induced internalization of
some receptors can also be mediated by caveolae [18].
In the present study, we have investigated the pathway of
EP4 receptor internalization in HEK 293-EBNA cells. We
examined whether EP4 receptor endocytosis requires L-arrest-
in- and dynamin-dependent mechanisms or a caveola-medi-
ated mechanism. In addition, recent studies have demon-
strated the requirement of L-arrestin- and dynamin-
dependent receptor endocytosis for activation of the mito-
gen-activated protein (MAP) kinase pathway [19,20]. In light
of this, we examined activation of MAP kinase by the EP4
receptor and its relationship to internalization of the receptor.
2. Materials and methods
2.1. Materials
HA monoclonal antibody (HA 11) was from Babco (Richmond,
CA, USA). Fluorescein isothiocyanate (FITC)-conjugated and Alexa
594-conjugated goat anti-mouse antibodies were from Molecular
Probes (Eugene, OR, USA). HEK 293-EBNA cells were from Invi-
trogen (Carlsbad, CA, USA). The cDNAs for green £uorescent pro-
tein (GFP)-arrestin 2, GFP-arrestin 3, dominant negative dynamin
(K44A) and L-arrestin (319^418) were kindly provided by Dr. Je¡rey
Benovic (Thomas Je¡erson University, Philadelphia, PA, USA).
2.2. Cell culture and transfection
HEK 293-EBNA cells were maintained in Dulbecco’s modi¢ed Ea-
gle’s medium (DMEM) supplemented with 10% fetal bovine serum,
250 Wg/ml geneticin to maintain expression of the EBNA-1 plasmid, in
5% CO2 at 37‡C. Transfection was carried out using Lipofectamine
2000 reagent (Gibco BRL, Grand Island, NY, USA) according to the
manufacturer’s instructions. Stable clones were selected using 200 Wg/
ml hygromycin B. HA-epitope-tagged EP4 receptor and the truncated
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mutant HA-t350 were prepared as described previously [8]. To exam-
ine the e¡ects of L-arrestin or dynamin on sequestration, cells were
transfected with 1 Wg/well of the dominant negative L-arrestin (319^
418) or dynamin in pcDNA3.
2.3. ELISA assay
ELISA was performed as described previously [8]. Brie£y, trans-
fected cells treated with 1 WM PGE2 or vehicle for 60 min were ¢xed
with 2% PFA. Cells were washed, blocked and treated with 1:1000
anti-HA monoclonal antibody (HA 11) for 30 min. Thereafter, cells
were washed, blocked and incubated with 1:1000 dilution of a goat
anti-mouse horseradish peroxidase-conjugated secondary antibody for
30 min. Lastly, cells were incubated with o-phenylenediamine with
30% hydrogen peroxide solution for 15 min, aliquots placed into 96
well plates containing concentrated sulfuric acid, and absorbance read
at 450 nm using a Perkin-Elmer microtiter plate reader. Results were
expressed relative to values obtained with untreated cells as percent
surface HA immunoreactivity.
2.4. Confocal microscopy
HEK 293-EBNA cells were grown on coverslips in six well plates
until 85% con£uent and then transfected. To examine the e¡ect of
GFP-arrestin 2 (L-arrestin) and GFP-arrestin 3 (L-arrestin 2) on EP4
receptor internalization, cells were co-transfected with 4 Wg of receptor
cDNA and 0.5 Wg of either GFP-arrestin 2 or 3. On the day of assay,
the cells were washed once with Hanks’ bu¡ered saline solution and
incubated with DMEM bu¡ered with 20 mM HEPES, pH 7.4. Cells
were treated with either vehicle or 1 WM PGE2 for 60 min and ¢xed
with 2% PFA. Cells were permeabilized with 0.05% Triton X-100 in
phosphate-bu¡ered saline, labeled with a 1:500 dilution of the pri-
mary anti-HA antibody for 30 min, washed and blocked with 5%
BLOTTO for 30 min at 37‡C and then incubated with a goat anti-
mouse Alexa 594 secondary antibody for 30 min at 37‡C. Fluores-
cence was examined using a Leica TCS-NT confocal microscope. Sin-
gle optical sections are presented, representing the average of eight
scans.
2.5. MAP kinase phosphorylation
HEK 293-EBNA cells stably expressing the HA-hEP4 receptor or
the truncated mutant receptor HA-t350 receptor were grown in six
well plates until 50^60% con£uent. On the day of the experiment, cells
were serum-starved for 1 h at 37‡C in DMEM and treated with 1 WM
PGE2. Reactions were stopped by rapidly removing agonist-contain-
ing medium and lysed by adding 200 Wl SDS sample bu¡er. The
samples were boiled, centrifuged, resolved by SDS^PAGE and trans-
ferred onto PVDF membranes for detection of phosphorylated MAP
kinase. Membranes were probed using a phospho-p44/42 MAP kinase
polyclonal antibody (1:2000) for 1 h (Cell Signaling Technology, Bev-
erly, MA, USA) and phosphorylated protein detected by ECL.
3. Results
3.1. E¡ect of dominant negative dynamin I (K44A) on
EP4 receptor internalization
To delineate the role of dynamin in agonist-induced inter-
nalization of EP4, we studied the e¡ect of the dynamin I
mutant K44A on HA-hEP4 receptor internalization. ELISA
analysis revealed that transfected dynamin K44A reduced ag-
onist-induced internalization of EP4 receptor from 40% to
15%, indicating that dynamin is involved in the process
(Fig. 1).
3.2. E¡ect of dominant negative L-arrestin 1 (319^418) on
EP4 internalization
To examine the involvement of arrestin in EP4 receptor
internalization, we co-expressed dominant negative L-arrestin
(319^418) or empty pcDNA3 vector with the HA-hEP4 recep-
tor. The L-arrestin (319^418) mutant inhibits receptor inter-
nalization by binding constitutively to clathrin [21]. Co-ex-
pression with EP4 resulted in reduced internalization from
40% to approximately 25% (Fig. 1). While the e¡ect of L-
arrestin (319^418) was not as pronounced as the e¡ect of
dynamin I (K44A), the results were statistically signi¢cant
as determined by a one way ANOVA.
3.3. Colocalization of GFP-arrestin 2 and GFP-arrestin 3 with
agonist-activated EP4 receptor
To examine the role of arrestins 2 and 3 in the agonist-
induced internalization of the EP4 receptor, we transiently
co-transfected EP4 cDNA with either GFP-arrestin 2 or
GFP-arrestin 3 to visualize the localization of each protein
under agonist-treated and untreated conditions. In the ab-
sence of PGE2, the EP4 receptor is localized primarily to
the plasma membrane while the arrestins are distributed
throughout the cytosol (Fig. 2a^c). Upon treatment with
1 WM PGE2 for 60 min, the receptor was internalized into punc-
tate compartments with a corresponding loss of surface £uo-
rescence (Fig. 2e,h). Agonist treatment also resulted in a punc-
tate distribution of GFP-arrestin 2 (Fig. 2d) and GFP-arrestin
3 (Fig. 2g), overlapping signi¢cantly with the internalized re-
ceptor (Fig. 2f,i). These results suggest that both arrestin 2
and arrestin 3 play a role in sequestration of the EP4 receptor.
3.4. E¡ect of acetic acid and PMA on EP4 receptor
internalization
To further examine EP4 receptor internalization via clath-
rin-coated vesicles, cells co-expressing both receptor and
GFP-arrestin 2 were pretreated with either 5 mM acetic
acid, to prevent clathrin-mediated internalization, or 1 WM
phorbol 12-myristate 13-acetate (PMA) to prevent caveola-
mediated internalization. Immuno£uorescence confocal mi-
croscopy of cells treated with acetic acid revealed that despite
Fig. 1. E¡ect of dominant accessory proteins on HA-hEP4 receptor
internalization. HEK 293-EBNA-HA-hEP4 cells were transfected
with either pcDNA3, dominant negative L-arrestin 1 (319^418) or
dynamin I (K44A). Cells were treated with vehicle or 1 WM PGE2
for 60 min. Surface HA immunoreactivity was measured by ELISA
and expressed as a percentage of samples not treated with PGE2.
Values represent the mean þ S.E.M. of four experiments, each done
in triplicate. Asterisks indicate P6 0.001 compared with wild-type
HA-hEP4 (+pcDNA3) according to a one way ANOVA.
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PGE2 stimulation, the HA-hEP4 receptor was still localized to
the plasma membrane, and there was also no visible trans-
location of GFP-arrestin 2 (Fig. 3d,e). The overlay shown in
Fig. 3f shows the lack of any signi¢cant co-localization. In
addition, pretreatment with PMA to prevent caveola-medi-
ated internalization had no e¡ect on EP4 receptor internal-
ization as illustrated in Fig. 3g^i, and the receptor and GFP-
arrestin 2 continued to co-localize, indicating that in HEK 293
cells, hEP4 receptor sequesters via clathrin-coated vesicles in
an arrestin- and dynamin-dependent manner.
3.5. Role of EP4 receptor internalization in MAP kinase
activation
PGE2 activation of HEK 293-EBNA cells stably expressing
the EP4 receptor resulted in rapid activation of MAP kinase
within 2 min, as detected by Western blotting. The amounts of
phosphorylated p42 and p44 were signi¢cantly higher than
basal levels (Fig. 4). However, agonist stimulation of cells
expressing the construct HA-t350, which is the severely trun-
cated EP4 receptor mutant, resistant in internalization capa-
bility [8], also resulted in rapid phosphorylation of MAP ki-
nase (Fig. 4), although the amount of phosphorylated MAP
kinase was lower than the observed level for wild-type EP4
receptor.
To further analyze the relationship between receptor inter-
nalization and MAP kinase phosphorylation, the e¡ect of the
dominant negative mutants dynamin-I (K44A) and L-arrestin
1 (319^418) was also studied. Because both dominant negative
proteins signi¢cantly reduced agonist-induced internalization
of hEP4, analysis of their e¡ect on PGE2-stimulated MAP
kinase activation via EP4 receptor would help to further ex-
amine the relationship between receptor internalization and
MAP kinase activation. Agonist stimulation of cells express-
ing either of these mutant accessory proteins revealed that
inhibition of internalization does not prevent activation of
the MAP kinase cascade (Fig. 5). HEK 293-EBNA cells trans-
Fig. 2. Co-localization of HA-hEP4 with GFP-arrestin 2 and GFP-
arrestin 3. HEK 293-EBNA cells were transiently co-transfected
with HA-hEP4 and either GFP-arrestin 2 or GFP-arrestin 3
cDNAs. Forty-eight hours after transfection, the cells were treated
with vehicle (a^c) or 1 WM PGE2 (d^i) for 60 min and then pro-
cessed for immuno£uorescence microscopy. a,d,g: Localization of
GFP-arrestin. b,e,h: Receptor localization. c,f,i : Overlay of the two
individual images. Regions of overlap are in yellow. Images are rep-
resentative of three to four individual experiments.
Fig. 3. E¡ect of acetic acid and PMA on HA-hEP4 receptor inter-
nalization. HEK 293-EBNA cells co-expressing HA-hEP4 and GFP-
arrestin 2 were preincubated with either 5mM acetic acid (d^f) for
5 min or 1 WM PMA (g^i) for 30 min at 37‡C and then treated
with either vehicle (a^c) or 1 WM PGE2 (d^i) for 30 min at 37‡C.
The cells were processed for detection of total receptor (surface and
internalized) and visualized using confocal microscopy. The middle
panel shows the e¡ect of acetic acid and the bottom panel shows
the e¡ect of PMA on PGE2-stimulated internalization. Images are
representative of 2 separate experiments.
Fig. 4. E¡ect of HA-hEP4 receptor internalization on MAP kinase
activation. HEK 293-EBNA cells stably expressing HA-hEP4, HA-
t350 or pCEP4 vector were serum-starved and then stimulated with
1 WM PGE2 for 0, 2, or 5 min at 37‡C. The samples were processed
for detection of phosphorylated p42 and p44 MAP kinase. Experi-
ments were repeated three times, with similar results.
Fig. 5. E¡ects of dominant negative accessory proteins on PGE2-in-
duced MAP kinase phosphorylation. HEK 293-EBNA-HA-hEP4
cells were transiently transfected with either dominant negative L-ar-
restin 1 (319^418), dynamin-I (K44A) or pcDNA3 vector. Forty-
eight hours after transfection, samples were processed for detection
of phosphorylated MAPK. Experiments were repeated twice with
similar results.
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fected with pCEP4 vector alone were used as a control to
validate the activation of MAP kinase in EP4 receptor trans-
fected cells.
4. Discussion
In the present report, we have shown that agonist-induced
internalization of the human EP4 receptor is mediated in a
dynamin- and L-arrestin-dependent pathway in HEK 293
cells. Co-expression of dominant negative dynamin I (K44A)
or L-arrestin (319^418) with the EP4 receptor reduced inter-
nalization from 40% to 15% and 25%, respectively, indicating
involvement of endogenous arrestin and dynamin. Dynamin I
is a GTPase that regulates the formation of clathrin-coated
vesicles and is involved in the ¢ssion of endocytic vesicles
from the plasma membrane [22]. Mutant dynamin I (K44A)
is defective in GTP binding and blocks endocytosis at a stage
after the initiation of coated vesicle formation but before se-
questration into coated pits [23]. The e¡ect of dynamin I
(K44A) on EP4 receptor sequestration was more pronounced
than L-arrestin (319^418). The partial e¡ect of this mutant L-
arrestin has been observed in studies with other GPCRs [24].
It is possible that the altered protein is not a very competitive
inhibitor of endogenous L-arrestin 1 or that it is not expressed
at a high enough concentration to produce a stronger e¡ect.
Nevertheless, the reversal of internalization by both mutants
was determined to be statistically signi¢cant.
An alternative approach would be to over-express wild-type
arrestin to enhance internalization. However, HEK 293 cells
have high endogenous levels of arrestins [21,25] so that over-
expression has a minimal e¡ect on receptor internalization
[25]. In other cell types, protein over-expression may cause
non-speci¢c e¡ects, forcing regulatory events to occur that
are not physiologically relevant.
The non-visual arrestins, arrestin 2 and arrestin 3, have
been implicated in receptor-mediated endocytosis of a number
of GPCRs. Particularly, they play an integral role as adapter
proteins in the agonist-induced internalization of the L2AR by
binding directly to clathrin, the major component of clathrin-
coated pits [14,16]. As further evidence for the involvement of
arrestins in EP4 receptor internalization, we showed that
GFP-L-arrestin 1 or 2 co-localize with the EP4 receptor fol-
lowing PGE2 stimulation.
We used acetic acid as a probe to examine the role of clath-
rin. Acetic acid causes acidi¢cation of vesicles, which in turn
prevents the pinching o¡ of clathrin-coated pits to form
coated vesicles [26]. Previously, acidi¢cation has been used
successfully in studies with other receptors that internalize
using a clathrin- and arrestin-dependent pathway. For exam-
ple, internalization of m1 mAChR was determined to seques-
ter via clathrin-coated vesicles using acetic acid to disrupt the
process [27]. Treatment of EP4-expressing cells with acetic
acid con¢rmed that the receptor internalization is mediated
by L-arrestin via clathrin-coated pits.
Activators of protein kinase C such as PMA have been
shown to prevent invagination of the caveolar membrane,
blocking caveola-mediated internalization [28]. Pretreatment
of EP4-expressing cells with 1 WM PMA had no e¡ect on
internalization and the stimulated receptor continued to co-
localize with GFP-arrestin 2, indicating that caveolae are not
involved.
A role for endocytosis in MAP kinase activation has been
proposed for the L2AR and the m1 mAChR [19,20]. We
showed that stimulation of the EP4 receptor also leads to
activation MAP kinase activation, however, internalization
does not appear necessary for activation. We previously
showed that the severely truncated mutant HA-t350 exhibits
sharply attenuated PGE2-induced internalization [8]. In the
present work, we show that HA-t350 rapidly phosphorylates
MAP kinase, independently of internalization capability.
Although agonist treatment of this truncated mutant contin-
ued to activate MAP kinase, phosphorylation was somewhat
reduced compared with wild-type receptor. The reduced phos-
phorylation may be explained by the fact that truncation of
the EP4 receptor eliminates sites in the carboxy tail that may
be required for MAP kinase activation. For example, a recent
report showed evidence that proline-rich regions in the third
intracellular loop and carboxy tail of the L3AR [29] interact
directly with the SH3 domains of Src to activate MAP kinase.
Such a mechanism of activation of MAP kinase is possible
because there is one PXXP motif in the carboxy tail of the
EP4 receptor that is removed by truncation at amino acid 350.
We also showed that expression of dominant negative L-
arrestin 1 (319^418) or dynamin I (K44A), both of which
signi¢cantly reduced internalization of the EP4 receptor, had
no e¡ect on EP4-mediated MAP kinase activation. In addi-
tion to our report, studies of other receptors have also indi-
cated that MAP kinase activation occurs independently of
receptor internalization. Examples of such studies are the
mu opioid receptor [24] and the K2-adrenergic receptor [30].
In summary, we have presented evidence that the prosta-
glandin EP4 receptor subtype internalizes rapidly by a dyna-
min- and arrestin-dependent mechanism. EP4 receptor stimu-
lation leads to activation of the MAP kinase cascade but this
activation does not depend on internalization of the receptor.
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